Last updated: 2026-09-16 10:32:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Inspire Medical Systems, Inc. (INSP) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $74.65, with a market capitalisation of $2.15B and a P/E ratio of 15.97. Over the past 52 weeks, its price has ranged from $38.91 to $147.03. This page covers its latest market performance, valuation, price trends and company information.
$2.15B | |
$74.58 | |
$330.00 | |
$5.07 | |
$74.60 | |
36.00 | |
855.63K | |
15.97 | |
$147.03 | |
$38.91 | |
-- | |
-- |
Inspire Medical Systems, Inc. (INSP) is trading at $74.65 in pre-market trading as of 2026-09-16 10:27:00, up 0.07% ($0.05) from the previous close of $74.60
Pre-market trading shows how investors are pricing INSP before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Inspire Medical Systems, Inc. (INSP) moved from $63.08 to $74.65, representing a gain of 18.34% ($11.57).
The stock traded between $60.00 and $75.29 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 970.06 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 33.1%
INSP is currently trading at $74.65, placing it 33.1% of the way from its 52-week low of $38.91 to its 52-week high of $147.03. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 1333 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Inspire Medical Systems, Inc. (INSP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.